Dr. Philip G Tibbo, MD

Claim this profile
Studies Alcoholism
Studies High Risk for Psychosis
1 reported clinical trial
1 drug studied

Clinical Trials Philip G Tibbo, MD is currently running

Image of trial facility.

Cognitive Enhancement Therapy

for Psychosis and Alcoholism

A focus of research for youth and Emerging Adults with early phase psychosis (EPP) has been cannabis use. However, this focus has led to overlooking the possible negative influence of another legal recreational drug, alcohol. Previous studies our research group has done have demonstrated that over use of alcohol reduces the effectiveness of early intervention in psychosis treatment services. These treatment services are wrap around services that address medical, and social needs of young people with psychosis. Individuals with alcohol use disorder and EPP have fewer positive symptoms such as hallucinations which are the aspects of psychotic disorders that respond most readily to medication but have greater levels of depressive symptoms. Biologically, we can see the negative impact of alcohol on brain structure in our MRI studies. Our aim presented in this grant is to pilot a psychosocial intervention using cognitive enhancement therapy to reduce alcohol consumption in individuals with early phase psychosis. This intervention has shown promise in reducing alcohol use in individuals with long standing schizophrenia and compare it to treatment as usual which involves brief (1 session) psychoeducation. The investigators hope to reduce substance use in young people in the early stages of a psychotic disorder and improve their odds of a full recovery. In addition to measuring symptoms and hospitalizations, this trial will measure what are called social determinants of health such as return to school or work and resumption of relationships. These variables have not been measured previously in alcohol use interventions in this population but in our experience are the best indicators of long term recovery from psychosis. The symptoms will generally improve with antipsychotic drug treatment but reach a threshold after 6 months in most individuals who engage with our 5 year program. Further functional and social recovery seem to be the best determinants of a full return to health in this population.
Recruiting1 award N/A

More about Philip G Tibbo, MD

Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Philip G Tibbo, MD has experience with
  • Cognitive Enhancement Therapy (CET)
Breakdown of trials Philip G Tibbo, MD has run
Alcoholism
High Risk for Psychosis
Mental Health Disorders
Alcohol Consumption
Psychosis

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Philip G Tibbo, MD specialize in?
Philip G Tibbo, MD focuses on Alcoholism and High Risk for Psychosis. In particular, much of their work with Alcoholism has involved treating patients, or patients who are undergoing treatment.
Is Philip G Tibbo, MD currently recruiting for clinical trials?
Yes, Philip G Tibbo, MD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Philip G Tibbo, MD has studied deeply?
Yes, Philip G Tibbo, MD has studied treatments such as Cognitive Enhancement Therapy (CET).
What is the best way to schedule an appointment with Philip G Tibbo, MD?
Apply for one of the trials that Philip G Tibbo, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top